Showing results (491-500 of 537) with videos related to
Sort By:
Pageof 54
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1981
Unusual phenotypes of human inducer T cells as measured by OKT4 and related monoclonal antibodiesM A Bach, F Phan-Dinh-Tuy, J F Bach, et al.The Diabetes Educator|September 21, 2013
Implementation of a culturally tailored diabetes intervention with community health workers in American SamoaJudith D DePue, Rochelle K Rosen, Andrew Seiden, et al.Oecologia|March 18, 2017
Gas exchange and water balance of a mistletoe species and its mangrove hostsG Goldstein, F Rada, L Sternberg, et al.Conservation Biology : the Journal of the Society for Conservation Biology|May 5, 2023
Creating conservation strategies with value-focused thinkingDavid M Martin, Joshua G Goldstein, David R Smith, et al.The Journal of Family Practice|April 3, 2002
Physician recruitment for a community-based smoking cessation interventionElyse R Park, Nancy A MacDonald Gross, Michael G Goldstein, et al.Suicide & Life-Threatening Behavior|September 17, 2021
Social media use and prospective suicidal thoughts and behaviors among adolescents at high risk for suicideJessica L Hamilton, Candice Biernesser, Megan A Moreno, et al.Journal of Chromatography. A|July 21, 1995
Peptide chiral purity determination: hydrolysis in deuterated acid, derivatization with Marfey's reagent and analysis using high-performance liquid chromatography-electrospray ionization-mass spectrometryD R Goodlett, P A Abuaf, P A Savage, et al.The Journal of Experimental Medicine|February 10, 2026
Liver-X-receptor agonism enhances T cell priming and activation to promote anti-tumor immunityBenjamin N Ostendorf, Jonathan G Goldstein, Shuang Liu, et al.The Journal of Pediatrics|May 1, 1990
Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipientsM R Leone, J M Barry, S R Alexander, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trialG Goldstein, M A Conant, G Beall, et al.Pageof 54